In thyroid tumorigenesis the only evidence in favour of the alteration of tumour-suppressor genes concerns the occurrence of p53 mutations, which appear to be restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland (Ito et al., 1992; Nakamura et al., 1992; Donghi et al., 1993; Fagin et al., 1993) . Germline mutations of the tumour-suppressor gene APC, located on the long arm of chromosome 5, are responsible for the predisposition to familial adenomatous polyposis (FAP). FAP is an autosomal dominant disorder characterised by the development, in young adults, of hundreds to thousands of adenomatous colonic polyps. FAP may be associated with osteomas, epidermoid cysts, fibromas and desmoid tumours, as well as with tumours of other tissues, including the thyroid, outlining the clinical picture of Gardner's syndrome (Gardner & Richards, 1953; Jarvinen & Sipponen, 1986; Jagelman et al., 1988) . Somatic mutations of the APC gene are also considered to be an early event in the development of sporadic gastrointestinal tumours (Powell et al., 1992) .
The association between FAP and thyroid carcinoma was first observed in 1949 (Crail, 1949) , and since then several cases have been reported in the literature (Delamarre et al., 1988; Ono et al., 1991; Bell & Mazzaferri, 1993) . The importance of this association has not been well established, but the development of a thyroid carcinoma in two sisters affected by FAP (Camiel et al., 1968) , and the high incidence of thyroid carcinoma observed in two different large series of patients with FAP (Plail et al., 1987; Bulow et al., 1988) , has suggested that the concurrence of the two diseases may not have arisen by chance.
In addition, APC has been found to be expressed in normal as well as in neoplastic human thyroid tissue, in which multiple forms of specific RNA transcripts have been detected (Horii et al., 1993; Zeki et al., 1993 (Miyoshi et al., 1992; Nakatsuru et al., 1991) , were amplified by the polymerase chain reaction (PCR) using primer pairs and incubation conditions previously described (Miyoshi et al., 1992) . (Cama et al., 1993) . DNA samples showing an abnormal SSCP electrophoretic profile were further analysed by direct sequencing of PCR products using the dideoxy chain-termination method (Kadowaki et al., 1990 remaining samples did not show alterations of the APC gene in any of the mutation cluster regions analysed (Figure 1) . Since 1949 the concurrence of FAP and thyroid carcinoma has been observed in 48 cases (Table I) . Most of the studies published have pointed to the fact that thyroid carcinoma occurs with an unexpectedly high frequency in patients affected by FAP. Recently, statistical analysis of data obtained from an English Polyposis Register has indicated that the risk for a young female affected by FAP of developing thyroid carcinoma, particularly of the papillary type, is about 160-fold higher than expected (Plail et al., 1987) . Similar conclusions have been obtained in a Danish population of FAP patients in which the risk of developing thyroid carcinoma has also been estimated to be 100-fold greater than in the general population (Billow et al., 1988) . Thyroid carcinoma associated with FAP has been more frequently found in young female patients (F/M = 6.3:1) than sporadic thyroid carcinoma (F/M = 2-3: 1). The thyroid neoplasia has usually been discovered within 1-7 years after FAP was diagnosed. Papillary carcinoma represented the predominant histotype (8.5%) with a 2-fold higher than expected frequency of multifocal lesions ( Table I) .
The patients with thyroid carcinoma examined in the present study were all females, did not show evidence of an altered bowel function and always had a negative family TC  24  31  20  29   19  20  19   <30   21  58  26  26  27  22  29  18  27  23  21  24  37  26  22  26  34  23  20  16  34  26  28  55  29  26  19   40  34 13   14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43   44  45  46  47  48 history for the presence of gastrointestinal diseases. Only one among the 13 cases of papillary thyroid carcinoma was multifocal. In this case, the occurrence of the same mutation in DNA extracted from two distinct tumoral foci, localized in opposite lobes of the same thyroid gland, but not in the corresponding extratumoral tissue (Figure 1, lane 28) , suggested a common clonal origin of the thyroid tumour.
The frequent association between FAP and thyroid carcinoma suggests the involvement of common mechanisms in the pathogenesis of these two diseases. However, the absence of germline and somatic APC gene defects in our series of 26 thyroid neoplasms, at different stages of dedifferentiation, suggests that alterations of this tumour-suppressor gene do not represent a frequent event in thyroid tumorigenesis.
The small number of cases analysed does not allow any statistically significant conclusion to be drawn, since a low incidence of APC mutations cannot be ruled out. However, our results are in agreement with recent unpublished observations (Varesco et al., 1993; Zeki et al., 1993) . SSCP analysis of a population of 73 benign and malignant thyroid tumours, performed on a 1,200 bp stretch of exon 15, also failed to detect any mutation in the APC gene. Only a nucleotide insertion, leading to a premature stop codon, was identified in one out of four thyroid carcinoma cell lines examined, namely the highly undifferentiated ARO carcinoma cells (Zeki et al., 1993) . APC gene mutations were also absent in a small group of thyroid tumours in which most of the APC gene coding region was investigated (Varesco et al., 1993) .
In conclusion, our own results and those of others, gathered from a total of more than 100 thyroid tumours, suggest that APC mutations do not play a pathogenetic role in thyroid tumorigenesis, at least in patients not affected by FAP. However, true estimates of the incidence of APC alterations in thyroid tumours will require the collection of molecular information from a larger number of cases.
